Evolent Health Inc (EVH) Receives $27.50 Consensus Target Price from Brokerages

Shares of Evolent Health Inc (NYSE:EVH) have received an average rating of “Buy” from the fifteen research firms that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $27.50.

A number of research firms recently commented on EVH. ValuEngine downgraded shares of Evolent Health from a “buy” rating to a “hold” rating in a report on Tuesday, January 29th. TheStreet downgraded shares of Evolent Health from a “c-” rating to a “d+” rating in a report on Friday, February 22nd. KeyCorp decreased their price objective on shares of Evolent Health from $32.00 to $20.00 and set an “overweight” rating on the stock in a report on Monday, March 4th. Cantor Fitzgerald reissued a “buy” rating and set a $37.00 price objective on shares of Evolent Health in a report on Monday, December 31st. Finally, Wells Fargo & Co decreased their price objective on shares of Evolent Health from $34.00 to $21.50 and set an “outperform” rating on the stock in a report on Wednesday, February 27th.

NYSE EVH traded down $0.10 during trading on Monday, reaching $13.51. The company’s stock had a trading volume of 15,350 shares, compared to its average volume of 1,212,000. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.81 and a current ratio of 1.81. The firm has a market cap of $1.13 billion, a PE ratio of -38.36 and a beta of 1.24. Evolent Health has a twelve month low of $12.09 and a twelve month high of $29.05.

Evolent Health (NYSE:EVH) last posted its quarterly earnings data on Tuesday, February 26th. The technology company reported ($0.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.02). The business had revenue of $193.10 million during the quarter, compared to analyst estimates of $188.66 million. Evolent Health had a negative net margin of 8.40% and a negative return on equity of 2.39%. The company’s revenue for the quarter was up 69.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.04) earnings per share. Research analysts predict that Evolent Health will post -0.81 earnings per share for the current year.

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Oppenheimer Asset Management Inc. increased its position in Evolent Health by 9.2% during the first quarter. Oppenheimer Asset Management Inc. now owns 169,973 shares of the technology company’s stock worth $2,138,000 after purchasing an additional 14,366 shares during the last quarter. Redmond Asset Management LLC boosted its stake in shares of Evolent Health by 2.3% in the first quarter. Redmond Asset Management LLC now owns 70,171 shares of the technology company’s stock valued at $883,000 after purchasing an additional 1,592 shares during the period. Pier Capital LLC boosted its stake in shares of Evolent Health by 99.3% in the first quarter. Pier Capital LLC now owns 667,999 shares of the technology company’s stock valued at $8,403,000 after purchasing an additional 332,820 shares during the period. Mercer Global Advisors Inc. ADV purchased a new position in shares of Evolent Health in the first quarter valued at $162,000. Finally, Trellus Management Company LLC purchased a new position in shares of Evolent Health in the first quarter valued at $315,000.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.

Featured Story: What is a Market Correction?

Analyst Recommendations for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.